- Home
- CELU vs RSF Comparison
CELU vs RSF Comparison
Compare CELU & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- RSF
- Stock Information
- Founded
- CELU 2016
- RSF 2016
- Country
- CELU United States
- RSF United States
- Employees
- CELU N/A
- RSF N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- RSF Investment Managers
- Sector
- CELU Health Care
- RSF Finance
- Exchange
- CELU Nasdaq
- RSF Nasdaq
- Market Cap
- CELU 56.9M
- RSF 63.1M
- IPO Year
- CELU N/A
- RSF N/A
- Fundamental
- Price
- CELU $2.06
- RSF $14.71
- Analyst Decision
- CELU Strong Buy
- RSF
- Analyst Count
- CELU 1
- RSF 0
- Target Price
- CELU $6.00
- RSF N/A
- AVG Volume (30 Days)
- CELU 171.3K
- RSF 11.8K
- Earning Date
- CELU 12-05-2025
- RSF 01-01-0001
- Dividend Yield
- CELU N/A
- RSF 10.61%
- EPS Growth
- CELU N/A
- RSF N/A
- EPS
- CELU N/A
- RSF N/A
- Revenue
- CELU $44,590,000.00
- RSF N/A
- Revenue This Year
- CELU N/A
- RSF N/A
- Revenue Next Year
- CELU $76.00
- RSF N/A
- P/E Ratio
- CELU N/A
- RSF N/A
- Revenue Growth
- CELU 4.45
- RSF N/A
- 52 Week Low
- CELU $1.00
- RSF $14.81
- 52 Week High
- CELU $5.22
- RSF $16.23
- Technical
- Relative Strength Index (RSI)
- CELU 44.82
- RSF 47.38
- Support Level
- CELU $1.94
- RSF $14.63
- Resistance Level
- CELU $2.06
- RSF $14.75
- Average True Range (ATR)
- CELU 0.14
- RSF 0.11
- MACD
- CELU 0.02
- RSF -0.01
- Stochastic Oscillator
- CELU 30.79
- RSF 27.59
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.